Virtual reality sessions lessen cancer pain in clinical trial

Results support adding this noninvasive, nonpharmacologic therapy to improve the health and quality of life of people with cancer.

2024-04-08

(Press-News.org) A 10-minute virtual reality (VR) session significantly lessened pain in hospitalized patients with cancer in a recent clinical trial published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Even a day later, participants experienced sustained benefits.

Most people with cancer experience pain, and treatment usually involves medications including opioids. VR sessions that immerse the user in new environments have been shown to be a noninvasive and nonpharmacologic way to lessen pain in different patient populations, but data are lacking in individuals with cancer. To investigate, Hunter Groninger, MD, of Georgetown University School of Medicine and MedStar Health and his colleagues randomized 128 adults with cancer with moderate or severe pain to a 10-minute immersive VR intervention involving calm, pleasant environments or to a 10-minute two-dimensional guided imagery experience on an iPad tablet.

The investigators found that both interventions lessened pain, but VR sessions had a greater impact. Based on patient-reported scores from 0 to 10, patients in the guided imagery group reported an average decrease of 0.7 in pain scores, whereas those in the VR group reported an average drop of 1.4. Twenty four hours after the assigned intervention, participants in the VR group reported sustained improvement in pain severity (1.7 points lower than baseline before the VR intervention) compared with participants in the guided imagery group (only 0.3 points lower than baseline before the active control intervention).

Participants assigned to the VR intervention also reported improvements related to pain “bothersomeness” (how much the pain bothered them, regardless of the severity of the pain) and general distress, and they expressed satisfaction with the intervention.

“Results from this trial suggest that immersive VR may be a useful non-medication strategy to improve the cancer pain experience,” said Dr. Groninger. “While this study was conducted among hospitalized patients, future studies should also evaluate VR pain therapies in outpatient settings and explore the impact of different VR content to improve different types of cancer-related pain in different patient populations. Perhaps one day, patients living with cancer pain will be prescribed a VR therapy to use at home to improve their pain experience, in addition to usual cancer pain management strategies like pain medications.”

Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com

Full Citation:
“Virtual reality for pain management in hospitalized patients with cancer: a randomized controlled trial.” Hunter Groninger, Diana Violanti, and Mihriye Mete. CANCER; Published Online: April 8, 2024 (DOI: 10.1002/cncr.35282).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.35282

Author Contact: Allison Kapson, AVP Research Communications, Marketing & PR, MedStar Health, at Allison.C.Kapson@medstar.net.

About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow CANCER on Twitter @JournalCancer and Instagram @ACSJournalCancer, and stay up to date with the American Cancer Society Journals on LinkedIn.

About Wiley
Wiley is a knowledge company and a global leader in research, publishing, and knowledge solutions. Dedicated to the creation and application of knowledge, Wiley serves the world’s researchers, learners, innovators, and leaders, helping them achieve their goals and solve the world's most important challenges. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, Twitter, LinkedIn and Instagram.

END

ELSE PRESS RELEASES FROM THIS DATE:

Cannabis use during pregnancy linked to increased risk of ADHD, autism and intellectual disability in children

2024-04-08

A new study presented at the European Psychiatric Association Congress 2024 reveals a significant association between prenatal cannabis use disorder (CUD) and an increased risk of neurodevelopmental disorders in offspring, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and intellectual disability (ID). Cannabis remains by far the most consumed illicit drug in Europe. Around 1.3% of adults in the European Union (3.7 million people) are estimated to be ...

New study highlights the link between depression and breast cancer mortality in women

2024-04-08

A new study presented at the European Psychiatric Association Congress 2024 sheds light on the significant impact of depression on the survival rates and quality of life for women diagnosed with breast cancer. This study, conducted by a team of researchers in Russia, conducted a comprehensive analysis of existing research on the prevalence and impact of depression in breast cancer patients. Breast cancer is the most common cancer among women and a leading cause of death globally and in the EU, it is estimated that 1 in 11 women in the EU-27 will develop breast cancer ...

Key to unlocking the secret of degenerative brain disorders found

2024-04-08

Alzheimer's disease and Parkinson's disease, along with stroke, are among the top three neurodegenerative disorders, characterized by the malfunction and progressive degeneration of neurons, the nerve cells. Understanding the mechanisms underlying these neurological disorders and developing therapies requires labeling technologies that can visualize neuronal changes not only in normal conditions but also in disease states. A research team led by Dr. Kim Yun Kyung from the Brain Science Institute at the Korea Institute of Science and Technology (KIST), in collaboration with Professor Chang Young-Tae's team from Pohang University of Science ...

Understanding the link between family physician characteristics and COVID-19 vaccination gaps

2024-04-08

New research examining the characteristics of physicians with the largest share of patients unvaccinated against SARS-CoV-2 may help increase vaccination rates going forward. The study, published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230816, found that family physicians in Ontario with the largest percentage of unvaccinated patients generally served patients living in marginalized neighbourhoods and had less support in their practices. Researchers analyzed linked data on 9060 family physicians with more than 10 million enrolled patients ...

Ontario’s proposed plan to broaden alcohol sales will harm people

2024-04-08

The Ontario government’s plans to broaden alcohol sales to privately operated stores in the province could lead to higher consumption rates and related harms, write commentary authors in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240069. “These changes will result in a 289% increase in the number of alcohol stores in Ontario (n = 2935 in March 2023, per the Liquor Control Board of Ontario), will likely reduce the price of alcohol, and will represent the biggest shift in decades with respect to how alcohol is sold in Canada,” write Drs. Norman Giesbrecht, Centre for Addiction and ...

Researchers identify an economic solution to Canada's opioid crisis

2024-04-08

Nasal-administered naloxone is more cost-effective and could help reduce the number of opioid-related fatalities compared to the current publicly funded intermuscular version, a new study has found. Since 2016, Canada's opioid crisis has worsened, with over 40,000 opioid-related deaths, or about 22 deaths per day. Most of these accidental deaths (88 per cent) occur in British Columbia, Alberta and Ontario. An effective way to help prevent opioid-related deaths is through community pharmacy-based naloxone programs. Currently, ...

Cancer stage compared with mortality as end points in randomized clinical trials of cancer screening

2024-04-08

About The Study: In this systematic review and meta-analysis that included 41 randomized clinical trials of cancer screening, incidence of late-stage cancer may be a suitable alternative end point to cancer-specific mortality for some cancer types, but is not suitable for others. These results have implications for clinical trials of multicancer screening tests. Authors: Hilary A. Robbins, Ph.D., M.H.S., M.S.P.H., of the International Agency for Research on Cancer in Lyon, France, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.5814) Editor’s ...

$2.3 trillion wasted globally in failed digital transformation programs – costly and complex business strategies are ‘not necessary’

2024-04-08

Strategies implemented by firms are too ambitious and wide-ranging, according to a specialist, with their poor design and structure preventing digital transformation success. Firms seeking to harness new digital technologies, such as artificial intelligence, must approach this organizational change in an entirely new way to avoid contributing to the $2.3 trillion wasted on unsuccessful projects globally so far. This is the message of digital transformation expert Brian Harkin, author of Evolving from Digital Transformation to Digital Acceleration Using The Galapagos Framework, which helps business leaders understand how their approach to digital change ...

Frequently need to pee? App-based therapy can help, finds research

2024-04-08

Combining pelvic floor exercises with behavioral therapy could be more effective than current medical treatments at helping men with frequent urges to urinate, new research in men has found. The initial results from the Bladder Emptying Disorder Therapy (BEST) Trial are presented today [Monday 8 April 2024] at the European Association of Urology Congress in Paris. They reveal that an app-based therapy leads to significant improvements in the lower urinary tract symptoms that many millions of men experience – hesitancy, straining, frequent urges to urinate and emptying the bladder effectively. Full results ...

Boreal forest and tundra regions worst hit over next 500 years of climate change, study shows

2024-04-08

The boreal forest, covering much of Canada and Alaska, and the treeless shrublands to the north of the forest region, may be among the worst impacted by climate change over the next 500 years, according to a new study. The study, led by researchers at the White Rose universities of York and Leeds, as well as Oxford and Montreal, and ETH, Switzerland, ran a widely-used climate model with different atmospheric concentrations of carbon dioxide to assess the impact climate change could have on the ...

Virtual reality sessions lessen cancer pain in clinical trial

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: